Djemli-Shipkolye A, Coste T, Raccah D, Vague P, Pieroni G, Gerbi A
Faculté de Médecine, Service de Diabétologie UPRES EA2193, Marseille, France.
Cell Mol Biol (Noisy-le-grand). 2001 Mar;47(2):297-304.
Type 1 diabetes induces several metabolic and biochemical disturbances which result in the alteration ofNa,K-ATPase, an enzyme implicated in the physiopathology of neuropathy Several fatty acid supplementations lessen this alteration. The aims of this study were to determine the possible relationships between Na,K-ATPase activity in nerves and red blood cells (RBCs) and, on one hand, the fatty acid alterations induced by diabetes in these tissues and plasma and on the other, on nerve physiological parameters. Two groups of rats, control and diabetic (n = 15), were sacrified 8 weeks after induction of diabetes with streptozotocin. Nerve conduction velocity (NCV), nerve blood flow (NBF), Na,K-ATPase activity and membrane fatty acid composition of sciatic nerves, red blood cells (RBCs) and plasma were measured. NCV, NBF and Na,K-ATPase activity in RBCs and in sciatic nerves were significantly decreased in diabetic rats. We revealed a positive correlation between Na,K-ATPase activity in sciatic nerves and both NBF and NCV and between Na,K-ATPase activity in RBCs and NBF and the same activity in sciatic nerve. Diabetes induced major changes in plasma fatty acids and RBC membranes and less important changes in sciatic nerve membranes. Na,K-ATPase activity correlated negatively with C20: 4 (n-6) and C22: 4 (n-6) levels in nerves and with C18: 2 (n-6) levels in RBCs. During diabetes, changes in the membrane fatty acid composition suggest the existence of a tissue-specific regulation, and the decrease in Na,K-ATPase activity correlates with the alteration in the level of specific fatty acids in RBCs and sciatic nerves. Modifications in the lipidic environment of Na,K-ATPase would be involved in the alteration of its activity. Na,K-ATPase activity seems to be implicated in the decrease of both NCV and NBF during diabetes.
1型糖尿病会引发多种代谢和生化紊乱,进而导致钠钾ATP酶发生改变,该酶与神经病变的病理生理学有关。几种脂肪酸补充剂可减轻这种改变。本研究的目的是确定神经和红细胞(RBC)中钠钾ATP酶活性之间的可能关系,一方面是糖尿病在这些组织和血浆中引起的脂肪酸改变,另一方面是神经生理参数。两组大鼠,对照组和糖尿病组(n = 15),在链脲佐菌素诱导糖尿病8周后处死。测量坐骨神经、红细胞(RBC)和血浆的神经传导速度(NCV)、神经血流量(NBF)、钠钾ATP酶活性和膜脂肪酸组成。糖尿病大鼠红细胞和坐骨神经中的NCV、NBF和钠钾ATP酶活性显著降低。我们发现坐骨神经中的钠钾ATP酶活性与NBF和NCV之间呈正相关,红细胞中的钠钾ATP酶活性与NBF以及坐骨神经中的相同活性之间呈正相关。糖尿病引起血浆脂肪酸和红细胞膜的主要变化,而坐骨神经膜的变化较小。钠钾ATP酶活性与神经中C20:4(n - 6)和C22:4(n - 6)水平以及红细胞中C18:2(n - 6)水平呈负相关。在糖尿病期间,膜脂肪酸组成的变化表明存在组织特异性调节,钠钾ATP酶活性的降低与红细胞和坐骨神经中特定脂肪酸水平的改变相关。钠钾ATP酶脂质环境的改变会涉及其活性的改变。钠钾ATP酶活性似乎与糖尿病期间NCV和NBF的降低有关。